XML 21 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Sep. 30, 2021
Revenue      
Royalty and option income $ 582 $ 3,944 $ 192
Cost of sales      
Depletion (216) (1,756) (164)
Gross profit 366 2,188 28
Expenses      
Consulting fees (158) (4,125) (2,677)
Depreciation (29) (72) 5
Management and directors' fees (377) (1,895) (1,172)
Salaries, wages and benefits (361) (1,103) (132)
Investor communications and marketing expenses (571) (1,410) (1,141)
Office and technology expenses (225) (811) (181)
Transfer agent and regulatory fees (93) (536) (190)
Insurance fees (438) (2,049) (1,293)
Professional fees (678) (4,249) (2,481)
Share-based compensation (1,078) (3,146) (3,324)
Mineral interest maintenance expenses (39) (229) (13)
Share of loss in associate 1 (296)  
Dilution gain in associate   100  
Impairment of royalty   (3,821)  
Operating loss for the period/year (3,680) (21,454) (12,581)
Other items      
Change in fair value on derivative liability 278 4,588 (1,511)
Change in fair value on short-term investments 1,060 (569) (168)
Foreign exchange gain 1 54 (813)
Interest expense (285) (633)  
Gain on loan modification   316  
Other income / (expense) (13) 337 67
Net loss before income taxes for the period/year (2,639) (17,361) (15,006)
Current tax expense   (114)  
Deferred tax recovery 435 129  
Net loss after income taxes for the period/year (2,204) (17,346) (15,006)
Item that may be reclassified subsequently to net income:      
Foreign currency translation differences 29 (145) 441
Total comprehensive loss for the period/year $ (2,175) $ (17,491) $ (14,565)
Net loss per share, basic and diluted $ (0.02) $ (0.14) $ (0.45)
Weighted average number of common shares outstanding, basic and diluted 143,913,069 128,232,364 33,555,265